GENINUS Inc. Logo

GENINUS Inc.

A biotech company offering genomic analysis for precision medicine and drug development.

389030 | KO

Overview

Corporate Details

ISIN(s):
KR7389030008
LEI:
Country:
South Korea
Address:
서울특별시 송파구 정의로 70 4층, 5층(문정동, 케이디유타워), 송파구

Description

GENINUS Inc. is a biotechnology company specializing in genomic and multi-omics analysis for precision medicine. The company provides comprehensive solutions for drug development, diagnostics, and clinical research, with a focus on single-cell analysis, cancer genome companion diagnostics, and AI-driven biomarker discovery. Its proprietary platforms include IntelliMed™ for clinical genomics, MEDINSIGHT™ for AI-powered digital pathology, and SPACEINSIGHT™, a cloud-based platform for spatial multi-omics data analysis. By integrating advanced analytics with artificial intelligence, GENINUS delivers genetic insights to support personalized treatment strategies, disease prevention, and the development of novel therapeutics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.6 MB
2025-05-28 00:00
주식등의대량보유상황보고서(약식)
Korean 73.6 KB
2025-05-22 00:00
증권발행결과(자율공시) (제1회차 CB)
Korean 5.6 KB
2025-05-19 00:00
주요사항보고서(전환사채권발행결정)
Korean 97.4 KB
2025-05-14 00:00
분기보고서 (2025.03)
Korean 1.5 MB
2025-04-03 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.9 KB
2025-03-27 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.0 KB
2025-03-25 00:00
정기주주총회결과
Korean 18.4 KB
2025-03-24 00:00
[기재정정]타인에대한채무보증결정
Korean 23.5 KB
2025-03-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-03-17 00:00
감사보고서제출
Korean 26.2 KB
2025-03-17 00:00
사업보고서 (2024.12)
Korean 436.9 KB
2025-03-14 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-03-10 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-03-06 00:00
주주총회소집공고
Korean 142.9 KB

Automate Your Workflow. Get a real-time feed of all GENINUS Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GENINUS Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GENINUS Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.